Erectile Rating During the Treatment of Rectal Cancers Localized. Exploratory Study
Erectile dysfunction will be explored by recording R / P and self-administered questionnaire
IIEF-5. This dual evaluation will be made before the beginning of the therapeutic treatment
and 3 months and 12 months after surgery. Assessed by IIEF-5 will be made only 6, 18 and 24
months after surgery. There will be no changes made to support oncology patients.
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
assess erectile dysfunction
Evaluate objectively the presence of erectile dysfunction induced by medico-surgical treatment of rectal cancer three months after surgery. These objective data will be obtained using the Rigiscan ® PLUS system coupled to a polysomnogram. the investigators use the abbreviation Register R / P (Rigiscan ® PLUS / polysomonographie) in this protocol.
EVRARD Serge, PU-PH
France: Committee for the Protection of Personnes